Pharmacological Treatment for Non-Alcoholic Fatty Liver Disease
Sven Francque
Luisa Vonghia
10.6084/m9.figshare.7667744.v2
https://adisjournals.figshare.com/articles/figure/Pharmacological_Treatment_for_Non-alcoholic_Fatty_Liver_Disease/7667744
<p>NASH= Non-alcoholic steatohepatitis </p><p><br></p><p>Full copyright for enhanced digital
features is owned by the authors.</p><p><br></p><p>
</p><p><strong>Article full
text</strong><br>
<br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-019-00898-6">here</a>.</p>
<p><br>
<strong>Provide enhanced digital features for this article</strong><br>
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to
provide complete transparency and adherence to good publication practices. This
ensures that however the content is reached the reader has a full understanding
of its origin. No fees are charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides</p><br><p></p>
2019-03-19 15:13:56
Cardiovascular disease
Clinical trials
Diabetes
Endpoints
Hepatology
Non-alcoholic Steatohepatitis
Pharmacological treatment